LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
96 hedge funds and large institutions have $672M invested in La Jolla Pharmaceutical Company in 2017 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
0% more call options, than puts
Call options by funds: $8.45M | Put options by funds: $8.43M
Holders
96
Holding in Top 10
4
Calls
$8.45M
Puts
$8.43M
Top Buyers
| 1 | +$45.1M | |
| 2 | +$42.4M | |
| 3 | +$27.2M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$24.5M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$18M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$7.14M | |
| 3 | -$4.49M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.91M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.7M |